糖尿病脑病发病机制的研究进展

关键词

糖尿病脑病 / 认知功能障碍 / 胰岛素抵抗 / 研究进展

[1] Chen YJ, Tang ZZ, Du L, et al.A novel compound AB-38b improves diabetes-associated cognitive decline in mice via activation of Nrf2/ARE pathway[J]. Brain Research Bulletin, 2019, 150: 160-167.
[2] Liu Y, Li M, Zhang Z, et al.Role of microglia-neuron interactions in diabetic encephalopathy[J]. Ageing Research Reviews, 2018, 42: 28-39.
[3] 刘申贝,古小云,钟志江,等. KKAy糖尿病脑病模型的探索及相关机制研究[J]. 中药药理与临床,2020,36(1):210-218.
[4] Kim B, Feldman EL.Insulin resistance in the nervous system[J]. Trends in Endocrinology Metabolism, 2012, 23(3): 133-141.
[5] Matulewicz N, Karczewska-Kupczewska M.Insulin resistance and chronic inflammation[J]. Advances in Hygiene and Experimental Medicine, 2016, 70: 1245-1258.
[6] Chen R, Shi J, Yin Q, et al.Morphological and pathological characteristics of brain in diabetic encephalopathy[J]. Journal of Alzheimer's Disease, 2018, 65(1): 15-28.
[7] Gokulakrishnan K, Mohanavalli KT, Monickaraj F, et al.Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and type 2 diabetes patients[J]. Molecular and Cellular Biochemistry, 2009, 324: 173-181.
[8] 徐敏,杨红英. 氧化应激与糖尿病脑病[J]. 国际检验医学杂志,2008,29(8):2.
[9] Powers ET, Morimoto RI, Dillin A, et al.Biological and chemical approaches to diseases of proteostasis deficiency[J]. Annual Review of Biochemistry, 2009, 78: 959-991.
[10] 师思,王晓良. 星形胶质细胞在糖尿病脑病中的变化及作用[J]. 国际药学研究杂志,2016,43(1): 6.
[11] Vargas R, Rincón J, Pedreañez A, et al.Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats[J]. Brain Research, 2012, 1453(1): 64-76.
[12] Ye X, Shen T, Hu J, et al.Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse[J]. Experimental Neurology, 2017, 292: 46-55.
[13] Hang CH, Shi JX, Tian J, et al.Effect of systemic LPS injection on cortical NF-κB activity and inflammatory response following traumatic brain injury in rats[J]. Brain Research, 2004, 1026(1): 23-32.
[14] Muranyi M, Fujioka M, He Q, et al.Diabetes activates cell death pathway after transient focal cerebral ischemia[J]. Diabetes, 2003, 52(2): 481-486.
[15] Tsukuda K, Mogi M, Li JM, et al.Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine[J]. Hypertension, 2008, 51(2): 528-533.
[16] Ly H, Despa F.Diabetes-related amylin dyshomeostasis: a contributing factor to cerebrovascular pathology and dementia[J]. Journal of Lipid and Atherosclerosis, 2019, 8(2): 144-151.
[17] Cantley J.The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis[J]. Mammalian Genome, 2014, 25(9-10): 442-454.
[18] Leal MC, Fernandez GA, Morelli L, et al.Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease[J]. Medicina, 2009, 69(4): 466-472.
[19] Dey A, Hao S, Wosiski-Kuhn M, et al.Glucocorticoid-mediated activation of GSK3β promotes tau phosphorylation and impairs memory in type 2 diabetes[J]. Neurobiology Aging, 2017, 57: 75-83.
[20] Chen Q, Mo R, Wu N, et al.Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats[J]. Frontiers in Pharmacology, 2017, 8: 334.
[21] Peng D, Pan X, Cui J, et al.Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment[J]. Cellular Physiology and Biochemistry, 2013, 32(5): 1417-1425.
[22] Vlassara H, Palace MR.Glycoxidation: the menace of diabetes and aging[J]. Mount Sinai Journal of Medicine New York, 2003, 70(4): 232.
[23] Luévano-Contreras C, Gómez-Ojeda A, Macías-Cervantes MH, et al.Dietary advanced glycation end products and cardiometabolic risk[J]. Current Diabetes Reports, 2017, 17: 1-11.
[24] Prasad YD, Sonia S, Balvinder S, et al.Advanced glycation end products: A review[J]. Sch Acad J Biosci, 2013, 45: 2185-2197.
[25] Liang W, Zhang D, Kang J, et al.Protective effects of rutin on liver injury in type 2 diabetic db/db mice[J]. Biomedicine Pharmacotherapy, 2018, 107: 721-728.
[26] Gan WJ, Gao CL, Zhang WQ, et al.Kuwanon G protects HT22 cells from advanced glycation end product-induced damage[J]. Experimental and Therapeutic Medicine, 2021, 21(5): 1-9.
[27] Saliu JA, Oboh G, Omojokun OS, et al.Effect of dietary supplementation of Padauk (Pterocarpus soyauxii) leaf on high fat diet/streptozotocin induced diabetes in rats’ brain and platelets[J]. Biomedicine Pharmacotherapy, 2016, 84: 1194-1201.
[28] Nieto-Estévez V, Defterali Ç, Vicario-Abejón C.IGF-I: A Key Growth Factor that Regulates Neurogenesis and Synaptogenesis from Embryonic to Adult Stages of the Brain[J]. Frontiers in Neuroscience, 2016, 10: 52.
[29] Jiang J, Chen Z, Liang B, et al.Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction[J]. Springerplus, 2015, 4(1): 1-7.
[30] 赵鹏举,刘洋,刘志海,等. 益肾解毒通络汤治疗糖尿病脑病肾虚瘀阻证的临床观察[J]. 河北中医,2023,45(4):578-582.
[31] 石晶晶. 当归芍药散及健脾利湿拆方对雌性糖尿病小鼠认知障碍改善作用的机制研究[D]. 广州: 广州中医药大学, 2021.
[32] 孙大伟,冯丽莎,吴晓翠,等. 基于Sirt1探讨糖尿病脑病"瘀毒阻络"中医病机及治法[J]. 中医学报,2019,34(8):4.

基金资助

河北省自然科学基金中医药联合基金重点项目（H2023209038）; 科技部对发展中国家科技援助项目（KY201904005）; 河北省高等学校科学技术研究项目（ZD2022141）